Can age and sex explain the variation in COPD rates across large urban cities? A population study in Canada

International Journal of Tuberculosis and Lung Disease

Volumn 15, Issue 12, 2011, Pages 1691-1696

  Tan, Wan C ^a   Bourbeau, J ^b   FitzGerald, J M ^a   Cowie, R ^c   Chapman, K ^d   Hernandez, P ^e   Buist, S A ^f   Sin, D D ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e DALHOUSIE UNIVERSITY   (Canada)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Age; COPD; Prevalence; Sex

Indexed keywords

ADULT; AGE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; URBAN AREA;

ADULT; AGE DISTRIBUTION; CANADA; FEMALE; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SMOKING; SPIROMETRY; URBAN POPULATION;

EID: 81455128865     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.11.0211     Document Type: Article

References (35)

1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. GOLD, 2009. http://goldcopd.org/Guidelineitem.asp?l1=2&l2= 1&intId=2003 Accessed August 2011.
2. Chapman K R, Bourbeau J, Rance L. The burden of COPD in Canada: results from the Confronting COPD survey. Respir Med 2003; 97 (Suppl C): S23-S31. (Pubitemid 36266867)
3. Lopez A D, Mathers C D, Ezzati M, Jamison D T, Murray C J. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006; 367: 1747-1757. (Pubitemid 43767064)
4. Mittmann N, Kuramoto L, Seung S J, Haddon J M, Bradley-Kennedy C, Fitzgerald J M. The cost of moderate and severe COPD exacerbations to the Canadian health care system. Respir Med 2008; 102: 413-421.
5. Statistics Canada. The Canadian Community Health Survey. Ottawa, ON, Canada: Statistics Canada, 2001. http://www.statcan.gc.ca/concepts/health-sante/ index-eng.htm Accessed August 2011.
6. Celli B R, Halbert R J, Isonaka S, Schau B. Population impact of different definitions of airway obstruction. Eur Respir J 2003; 22: 268-273. (Pubitemid 36986996)
7. O'Donnell D E, Hernandez P, Kaplan A, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2008 update - highlights for primary care. Can Respir J 2008; 15 (Suppl A): 1A-8A. (Pubitemid 351566057)
8. Rabe K F, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532-555. (Pubitemid 47403272)
9. Buist A S, McBurnie M A, Vollmer W M, et al. International variation in the prevalence of COPD (the BOLD Study): a p opulation-based prevalence study. Lancet 2007; 370: 741-750. (Pubitemid 47321907)
10. Menezes A M, Perez-Padilla R, Jardim J R, et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005; 366: 1875-1881. (Pubitemid 41690116)
11. Buist A S, Vollmer W M, Sullivan S D, et al. The Burden of Obstructive Lung Disease Initiative (BOLD): rationale and design. COPD 2005; 2: 277-283. (Pubitemid 40993302)
12. Tan W, Sin D, Balson D, et al. The Burden of Obstructive Lung Disease (BOLD) study in Vancouver, Canada - sampling and recruitment. Can Respir J 2007; 14 (Suppl A): 7A-9A. (Pubitemid 47090861)
13. Manfreda J, Becklake M R, Sears M R, et al. Prevalence of asthma symptoms among adults aged 20-44 years in Canada. CMAJ 2001; 164: 995-1001. (Pubitemid 34412227)
14. Methvin J N, Mannino D M, Casey B R. COPD prevalence in southeastern Kentucky: the burden of lung disease study. Chest 2009; 135: 102-107.
15. Statistics Canada. Household Facilities and Equipment Survey 2008. Ottawa, ON, Canada: Statistics Canada, 2008. http://www.statcan.gc.ca/bsolc/olc- cel/olc-cel?catno=62M0004XCB &lang=eng Accessed August 2011.
16. Statistics Canada. Census geography, census metropolitan a reas - 2001 census. Ottawa, ON, Canada: Statistics Canada, 2001. http://www12.statcan.ca/ census-recensement/index-eng.cfm Accessed August 2011.
17. Potthoff R F. Telephone sampling in epidemiologic research: to reap the benefits, avoid the pitfalls. Am J Epidemiol 1994; 139: 967-978. (Pubitemid 24156693)
18. Waksberg J. Random digit dialing sampling for case-control studies. In: Armitage P C T, ed. Encyclopedia of biostatistics. New York, NY, USA: John Wiley, 1998: pp 3678-3682.
19. Miller M R, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005; 26: 319-338. (Pubitemid 41079078)
20. Hankinson J L, Odencrantz J R, Fedan K B. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med 1999; 159: 179-187. (Pubitemid 29036522)
21. Hardie J A, Buist A S, Vollmer W M, Ellingsen I, Bakke P S, Morkve O. Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J 2002; 20: 1117-1122. (Pubitemid 35331867)
22. 1/FVC<70% as a criterion of COPD? Respir Med 2007; 101: 1097-1105.
23. Perez-Padilla R, Hallal P C, Vazquez-Garcia J C, et al. Impact of bronchodilator use on the prevalence of COPD in population-based samples. COPD 2007; 4: 113-120. (Pubitemid 47164863)
24. 1/FVC ratio reduces the misclassification of airway obstruction. Thorax 2008; 63: 1046-1051.
25. Vollmer W M, Gislason T, Burney P, et al. Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study. Eur Respir J 2009; 34: 588-597.
26. Caballero A, Torres-Duque C A, Jaramillo C, et al. Prevalence of COPD in five Colombian cities situated at low, medium, and high altitude (PREPOCOL study). Chest 2008; 133: 343-349. (Pubitemid 351272390)
27. Pena V S, Miravitlles M, Gabriel R, et al. Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest 2000; 118: 981-989.
28. Zhong N, Wang C, Yao W, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am J Respir Crit Care Med 2007; 176: 753-760. (Pubitemid 47598476)
29. Mannino D M, Gagnon R C, Petty T L, Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2000; 160: 1683-1689. (Pubitemid 30367908)
30. 1/FVC ratio of 70% misclassifies patients with obstruction at the extremes of age. Chest 2006; 130: 200-206.
31. Talamo C, de Oca M M, Halbert R, et al. Diagnostic labeling of COPD in five Latin American cities. Chest 2007; 131: 60-67. (Pubitemid 46122975)
32. Hill K, Goldstein R S, Guyatt G H, et al. Prevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary care. CMAJ 2010; 182: 673-678.
33. Anthonisen N R, Connett J E, Murray R P. Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med 2002; 166: 675-679. (Pubitemid 34971849)
34. Anthonisen N R, Skeans M A, Wise R A, Manfreda J, Kanner R E, Connett J E. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med 2005; 142: 233-239. (Pubitemid 40216240)
35. Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 2004; 328: 1519.